Loading clinical trials...
Loading clinical trials...
The treatment of helicobacter pylori is very important. The routine treatment is quadruple therapy. In recent years, double therapy has appeared and the curative effect is fair. However, antacid gener...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
First People's Hospital of Hangzhou
NCT05762991 · Helicobacter Pylori Infection, Premalignant Lesion
NCT07537634 · Helicobacter Pylori Infection, Dyspepsia, and more
NCT07516262 · Helicobacter Pylori Infection
NCT07335406 · HELICOBACTER PYLORI INFECTIONS
NCT07179159 · HELICOBACTER PYLORI INFECTIONS
Hangzhou first people's Hospital
Hangzhou, Zhejiang
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions